| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/27/2001 | CN1300734A Polypeptide-beta-transducin 41 and polynucleotide for coding this polypeptide |
| 06/27/2001 | CN1300547A Gene for coding plant growth regulator and its expression product and application |
| 06/27/2001 | CN1067726C Monoclonal antibody for recognizing interstitial cell surface antigen |
| 06/27/2001 | CN1067723C Gene Transferring system for target gene therapy of acceptor transducing |
| 06/27/2001 | CN1067722C Adenoviral vectors |
| 06/27/2001 | CN1067721C Hepatitis B surface antigen containing front surface antigen 1 and 2. immunodeterminant |
| 06/27/2001 | CN1067719C Method for external gene conversion for spiruline |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6252141 Nucleotide sequences coding an enzymatic polypeptide associated with biosynthesis of beta carotene in genetically engineered bacteria |
| 06/26/2001 | US6252140 Transformed plant cell contains expression cassette comprising promoter or mutant thereof corresponding to promoter from chlorella virus dna methyltransferase gene operably linked to dna sequence and nontranslated regulatory dna sequence |
| 06/26/2001 | US6252139 Generating genetically engineered plants; incubate cells with nucleotide sequence coding cyclin protein, transform cells, propagate cells, isolate plants with amplified root propagation |
| 06/26/2001 | US6252138 Nucleotide sequences coding nematocide; for the production of disease resistant plants |
| 06/26/2001 | US6252137 Soybean homolog of seed-specific transcription activator from Phaseolus vulgaris |
| 06/26/2001 | US6252136 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems |
| 06/26/2001 | US6252135 Production of syringyl lignin in gymnosperms |
| 06/26/2001 | US6252134 Generating plant with amplified baked goods qualities; transform wheat cell, propagate cell, recover wheat plants |
| 06/26/2001 | US6252133 Regenerating embryo of mammal; transfer nucleus of diploid cell into oocyte, activate and develop embryo |
| 06/26/2001 | US6252132 Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor |
| 06/26/2001 | US6252131 Transgenic mammal having 5-HT3 transgene overexpression in the CMS |
| 06/26/2001 | US6252130 Production of somatic mosaicism in mammals using a recombinatorial substrate |
| 06/26/2001 | US6252059 Oligonucleotides; for the detection and counting of preferential viral nucleic acids |
| 06/26/2001 | US6252058 Genetically engineered nucleotide sequences; for the evaluation, diagnosis and treatment of tumors defects |
| 06/26/2001 | US6252056 Membrane protein; for use as diagnostic tools in the treatment of vasospasms |
| 06/26/2001 | US6252051 ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor |
| 06/26/2001 | US6252047 Polypeptide associated with the diagnosis, treatment and prevention of cancer; antitumor agents |
| 06/26/2001 | US6252046 Protein for the treatment of kidney defects |
| 06/26/2001 | US6252044 Riboflavin synthase polypeptide; for the controlled biosynthesis of riboflavin; for screening bactericides; for prevention of infection |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251957 Preventing neutralizing antibodies; gene therapy |
| 06/26/2001 | US6251951 Cinnamic aldehyde as fungicide |
| 06/26/2001 | US6251873 Antisense compounds to CD14 |
| 06/26/2001 | US6251871 Administering pharmaceutical composition comprising adenoviral vector comprising promoter functional in eukaryotic cells and nucleic acid encoding p16 and buffer, solvent or diluent to mammal to inhibit tumor growth |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 06/26/2001 | US6251865 Insulin-like growth factor agonist molecules |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251691 Monitoring migration of particles suspended at an interface between an electrode and an electrolyte solution; generate electric potential, illuminate the surface, monitor movement of particles |
| 06/26/2001 | US6251682 Method and markers for prognosticating efficacy of anticancer agents |
| 06/26/2001 | US6251677 Genetically engineered microorganism; for use in gene therapy |
| 06/26/2001 | US6251676 Mammalian cell two-hybrid system |
| 06/26/2001 | US6251675 Modifying cell by delivering mutant rev gene having mutation from amino acid position 68 to 90 of the wild-type protein; intracellular immunization |
| 06/26/2001 | US6251674 Evolution of whole cells and organisms by recursive sequence recombination |
| 06/26/2001 | US6251671 Culturing mammalian spermatogonial stem cells with bone morphogenetic protein 8 to cause proliferation of the stem cells and survival of spermatocytes |
| 06/26/2001 | US6251669 Mammalian, non-tumor derived cells which divide, express neuron-specific markers, and give rise to progeny which differentiate into neuronal cells; for transplantation in treatment of alzheimer's/parkinson's diseases |
| 06/26/2001 | US6251668 Amino acid and nucleotide sequences; transformed cells |
| 06/26/2001 | US6251667 Amino acid sequence; controlling gene expression to increase or decrease production of proteins |
| 06/26/2001 | US6251666 Ribozyme with at least one l-nucleotide substitution; nuclease resistance |
| 06/26/2001 | US6251663 Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases |
| 06/26/2001 | US6251661 Seamless capsule for synthesizing biopolymer and method for producing the same |
| 06/26/2001 | US6251659 Biological sample treating apparatus |
| 06/26/2001 | US6251656 Insecticidal protein fragments |
| 06/26/2001 | US6251655 Dna sequence of phenylacetyl-coenzyme a ligase; recombinant culture production |
| 06/26/2001 | US6251654 Modified small RNA viruses |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251651 Protein-deamidating enzyme, gene encoding the same, production process therefor, and use thereof |
| 06/26/2001 | US6251650 Pseudomonas putida amidase polypeptide useful for the production of chiral amides and acids |
| 06/26/2001 | US6251649 Thermostable flap endonuclease derived from a hyperthermophile bacterium belonging to the genus pyrococcus |
| 06/26/2001 | US6251647 Nucleotide and amino acid sequences; drug screening of bactericides for staphylococcus infections |
| 06/26/2001 | US6251645 Leflunomide-resistant helicase; anticarcinogenic agents; antidiabetic agents; immunosuppressants; treatment of alzheimer's disease, atherosclerosis, osteoporosis, autoimmune disorders, and rheumatoid arthritis |
| 06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
| 06/26/2001 | US6251639 Methods and compositions for linear isothermal amplification of polynucleotide sequences, using a RNA-DNA composite primer |
| 06/26/2001 | US6251637 Cycle sequencing of dna using dideoxynucleotides labeled with marker dye usable at or near optimum chain elongation temperature and on gc-rich sequences |
| 06/26/2001 | US6251636 Recombinant oleandolide polyketide synthase |
| 06/26/2001 | US6251635 Condensing an n-terminal fragment of defined amino acid sequence with recombinantly-formed polypeptide of defined amino acid sequence in presence of non-enzymatic coupling reagent |
| 06/26/2001 | US6251634 Recombinant dna encoding gp63 glycoprotein of defined amino acid sequence; recombinant culture production; vaccines |
| 06/26/2001 | US6251633 Polynucleotides encoding Staphylococcus aureus FtsA polypeptide |
| 06/26/2001 | US6251630 Polynucleotide encoding member of ribonuclease family of defined amino acid sequence; diagnosis; bacteriostats; bactericides; vaccines; treatment of otitis media, pneumonia, conjunctivitis, bacteremia, meningitis, sinusitis, and others |
| 06/26/2001 | US6251629 Nucleotide sequence of transport protein from staphylococcus; recombinant culture production; drug screening; bacteriostats; bactericides; probes; primers; vaccines |
| 06/26/2001 | US6251628 Isolated nucleic acid molecules encoding Smad7 |
| 06/26/2001 | US6251627 Antigen presenting system and methods for activation of T-cells |
| 06/26/2001 | US6251626 Generating enzymatic polypeptide; insert expression vector into cell, culture cells, recover enzymatic polypeptide |
| 06/26/2001 | US6251623 Quick assay method for the activity of a plant-derived, asparagine residue-specific endoprotease |
| 06/26/2001 | US6251617 Screening for modulators of glycine transport; incubate cells with modulator and measure amount of glycine transport activity |
| 06/26/2001 | US6251614 Rapid methods for identifying modifiers of cellular apoptosis activity |
| 06/26/2001 | US6251613 Method for detecting anti-GADII antibody and method for diagnosing cancer using said detection method |
| 06/26/2001 | US6251612 Hybridoma; cheap and sensitive monitoring of water pollution |
| 06/26/2001 | US6251610 Generating single stranded sequences from deoxyribonucleic acids; amplify deoxyribonucleic acids, denature amplified nucleic acids, hybridize with single stranded nucleic acids, elongate single stranded sequence and denature products |
| 06/26/2001 | US6251609 Nucleotide sequences for detection of microorganismal infection |
| 06/26/2001 | US6251604 Random mutagenesis and amplification of nucleic acid |
| 06/26/2001 | US6251603 Evaluating cancer in humans; detect preferential gene expression in tumor, mix sample with antibodies which bind preferential protein, count amount of protein, an amplified protein value indicates adjustment in cancer classification |
| 06/26/2001 | US6251602 Cell systems having specific interaction of peptide binding pairs |
| 06/26/2001 | US6251601 Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays |
| 06/26/2001 | US6251599 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 06/26/2001 | US6251598 Methods for diagnosing sepsis |
| 06/26/2001 | US6251597 Methods for detecting fohy030 |
| 06/26/2001 | US6251593 Regulatory sequences which are induced by maltose; for use in development of fungicides; for use in control of cell propagation |
| 06/26/2001 | US6251590 Differential Qualitative screening |
| 06/26/2001 | US6251586 Epithelial protein and DNA thereof for use in early cancer detection |
| 06/26/2001 | US6251585 Assay and reagents for identifying anti-proliferative agents |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251407 And adjuvant selected from manganese gluconate, calcium gluconate, zinc gluconate, calcium fructoheptonate, zinc glucoheptonate, or calcium glycerophosphate and an oily phase ester of ethoxylated fatty acids; immunostimulatory |
| 06/26/2001 | US6251406 Attenuated microorganism strains and their uses |
| 06/26/2001 | US6251405 Comprising borrelia burgdorferi outer surface protein (osp)c antigen and a second antigenic lipoprotein such as recombinant ospa, or streptococcus pneumoniae cell surface protein (pspa), both in same physio-chemical form |
| 06/26/2001 | US6251404 Collecting a sample of a naturally occurring isolated virus such as the iowa strain, and a naturally occuring strain that causes lesions in colostrum deprived piglets, treating to deactivate virus and admixing with carrier |
| 06/26/2001 | US6251403 Comprising a foreign dna encoding a cytokine inserted into a swinepox virus genome within a nonessential region and expressed in a host cell into which the virus is introduced; swinepox virus as a vector for delivery of vaccine antigens |
| 06/26/2001 | US6251398 Fusion proteins comprising transport proteins comprising sequences from herpesviral vp22 or fragments thereof together with an antigenic sequence greater than 12 amino acids in length |
| 06/26/2001 | US6251397 Purified polypeptides encoded by open reading frames (orf's) of a highly virulent strain of the virus as determined by its ability to induce lung lesions in 51.9% of colostrum-deprived piglets; vaccines |
| 06/26/2001 | US6251393 Conformation-specific anti-von Willebrand Factor antibodies |
| 06/26/2001 | US6251390 Purified chitinases and use thereof |
| 06/26/2001 | US6251389 Human nucleotide pyrophosphohydrolase-2 |
| 06/26/2001 | US6251387 Topoisomerase I |